window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Clinical Data

  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
  • Events and Conferences,Patient Centricity,Pharmaceuticals and therapeutics,Real world evidence,Research & Development

    EADV 2025: Almirall showcases real-world evidence and pipeline progress in dermatology

    Almirall, a global biopharmaceutical company focused on medical dermatology, has [...]

    September 22, 2025
  • Clinical Development,Clinical Trials,Technology and platforms

    PHARMASEAL and Viedoc integrate platforms to streamline clinical trial oversight

    Partnership combines PHARMASEAL’s trial management technology with Viedoc’s electronic data [...]

    July 9, 2025
  • Clinical Development,Drug Development,Regulatory Affairs,Technology and platforms

    Certara expands clinical data collaboration with Merck to enhance digital trial efficiency

    Merck to broaden use of Certara’s Pinnacle 21 platform, adding [...]

    July 9, 2025
  • Artificial Intelligence,Clinical Trials,Regulatory Affairs

    Clinical trial innovation hampered by change fatigue and skills gaps, survey finds

    A new survey from eClinical Solutions reveals that biopharma organizations [...]

    May 27, 2025
  • Artificial Intelligence,Clinical Trials

    Lokavant launches AI-powered forecasting tool to cut clinical trial planning time from weeks to minutes

    April 25, 2025
  • Clinical Trials

    Shilpa Medicare’s Nor-UDCA tablets advance in India: SEC recommends marketing authorization following positive phase 3 results

    April 22, 2025
  • Clinical Trials

    AI appetite slows as clinical trial leaders refocus on risk-based strategies

    April 22, 2025
  • Artificial Intelligence

    New research from eClinical Solutions highlights AI adoption and focus on risk-based strategies in 2025

    June 5, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top